These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3055964)

  • 1. Disposition of IgA-containing circulating immune complexes.
    Hebert LA
    Am J Kidney Dis; 1988 Nov; 12(5):388-92. PubMed ID: 3055964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA nephropathy: clearance kinetics of IgA-containing immune complexes.
    Chen A; Yang SS; Lin TJ; Ka SM
    Semin Immunopathol; 2018 Nov; 40(6):539-543. PubMed ID: 30218212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin-antiimmunoglobulin interactions and immune complexes in IgA nephropathy.
    Jackson S
    Am J Kidney Dis; 1988 Nov; 12(5):425-9. PubMed ID: 3055969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of nephritogenic IgA immune complexes.
    Rifai A
    Am J Kidney Dis; 1988 Nov; 12(5):402-5. PubMed ID: 3189324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis of IgAN.
    Barratt J; Smith AC; Molyneux K; Feehally J
    Semin Immunopathol; 2007 Nov; 29(4):427-43. PubMed ID: 17851660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IgA receptors in the pathogenesis of IgA nephropathy.
    Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
    J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.
    Xie X; Liu P; Gao L; Zhang X; Lan P; Bijol V; Lv J; Zhang H; Jin J
    J Pathol; 2021 Jun; 254(2):159-172. PubMed ID: 33660264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular immune deposits in experimental IgA nephropathy. A continuum of circulating and in situ formed immune complexes.
    Chen A; Wong SS; Rifai A
    Am J Pathol; 1988 Jan; 130(1):216-22. PubMed ID: 3276211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular disease: sugars and immune complex formation in IgA nephropathy.
    Barratt J; Eitner F
    Nat Rev Nephrol; 2009 Nov; 5(11):612-4. PubMed ID: 19855421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
    Montinaro V; Esparza AR; Cavallo T; Rifai A
    Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition of IgA-containing circulating immune complexes in IgA nephropathy.
    van Es LA; van den Wall Bake AW; Valentijn RM; Daha MR
    Am J Kidney Dis; 1988 Nov; 12(5):397-401. PubMed ID: 3055965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy.
    Kolka R; Valdimarsson H; Bodvarsson M; Hardarson S; Jonsson T
    APMIS; 2013 Sep; 121(9):890-7. PubMed ID: 23398317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Haemophilus parainfluenzae antigens in IgA nephropathy].
    Suzuki S; Kimura H; Gejyo F
    Rinsho Byori; 1998 Jan; 46(1):17-25. PubMed ID: 9492534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of polymeric IgA in complement-mediated solubilization of IgG and IgA immune complexes.
    Schena FP; Pastore A; Montinaro V
    Am J Kidney Dis; 1988 Nov; 12(5):433-6. PubMed ID: 3055971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation in experimental IgA nephropathy: an antigen-mediated process.
    Rifai A; Chen A; Imai H
    Kidney Int; 1987 Dec; 32(6):838-44. PubMed ID: 3430967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro solubilization of glomerular immune deposits after incubation with human IgG and IgA in membranous and IgA nephropathy.
    Cirami C; Finato V; Andreini B; Bianchi AM; Panichi V; Montagnani E; Parrini M; Gattai V; Casarosa L; Palla R
    Clin Nephrol; 1993 Sep; 40(3):185. PubMed ID: 8403576
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoregulatory factors in the pathogenesis of IgA nephropathy.
    Emancipator SN
    Kidney Int; 1990 Dec; 38(6):1216-29. PubMed ID: 2074665
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of macromolecular IgA in IgA nephropathy.
    van der Boog PJ; van Kooten C; de Fijter JW; Daha MR
    Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPAK plays a pathogenic role in IgA nephropathy through the activation of NF-κB/MAPKs signaling pathway.
    Lin TJ; Yang SS; Hua KF; Tsai YL; Lin SH; Ka SM
    Free Radic Biol Med; 2016 Oct; 99():214-224. PubMed ID: 27519267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.